title: Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
authors.affiliation: Dept. of Hematology and Dept. of Microbiology, George Papanicolaou General Hospital, Thessaloniki, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Fassas
authors.forename: T
authors.initials: T
authors.lastname: Papageorgiou
authors.forename: A
authors.initials: A
authors.lastname: Kontodimou
authors.forename: E
authors.initials: E
authors.lastname: Proya
authors.forename: M
authors.initials: M
authors.lastname: Hadjikyrkou
authors.forename: A
authors.initials: A
authors.lastname: Anagnostopoulos
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000097:blood; D001424:Bacterial Infections / Q000097:blood* / Q000188:drug therapy; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000382:microbiology*; D009503:Neutropenia / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination